rp 73401 has been researched along with dipyridamole in 2 studies
Studies (rp 73401) | Trials (rp 73401) | Recent Studies (post-2010) (rp 73401) | Studies (dipyridamole) | Trials (dipyridamole) | Recent Studies (post-2010) (dipyridamole) |
---|---|---|---|---|---|
92 | 0 | 23 | 7,826 | 881 | 632 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bower, S; Bruno, J; Djuric, S; Hanney, B; McGarry, D; Miller, B; Poli, G; Regan, J; Souness, J; Sweeney, D; Travis, J | 1 |
Ashton, TD; Bland, ND; Campbell, RK; Cotter, K; Fang, AP; Gangurde, R; Garceau, N; Gechijian, L; Gustafson, AE; McAllister, G; Ochiana, SO; Ondrechen, MJ; Ortenberg, R; Pollastri, MP; Tallman, C; Wang, C; Wang, Z | 1 |
2 other study(ies) available for rp 73401 and dipyridamole
Article | Year |
---|---|
2-Substituted-4-methoxybenzimidazole-based PDE4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 4; Kinetics; Mice; Oxidation-Reduction; Phosphodiesterase Inhibitors; Rats; Solubility; Structure-Activity Relationship | 1998 |
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catalytic Domain; Humans; Models, Molecular; Molecular Structure; Pyridines; Recombinant Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2011 |